STOCK TITAN

Icahn Enterprises L.P. (Nasdaq: IEP) Today Announced Its First Quarter 2025 Financial Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Negative)
Tags
Icahn Enterprises (IEP) reported significant losses in Q1 2025, with a net loss of $422 million ($0.79 per unit), compared to a loss of $38 million in Q1 2024. The company's revenues declined to $1.9 billion from $2.5 billion year-over-year. Adjusted EBITDA showed a loss of $287 million, compared to positive $134 million in Q1 2024. The company's indicative net asset value decreased by $336 million to $3.0 billion, primarily due to $224 million losses in the Investment segment, particularly in healthcare. Despite challenges, IEP declared a quarterly distribution of $0.50 per depositary unit, payable on June 25, 2025, though this represents a 50% reduction from the $1.00 distribution in Q1 2024.
Icahn Enterprises (IEP) ha riportato perdite significative nel primo trimestre del 2025, con una perdita netta di 422 milioni di dollari (0,79 dollari per unità), rispetto a una perdita di 38 milioni di dollari nel primo trimestre del 2024. I ricavi dell'azienda sono scesi a 1,9 miliardi di dollari dai 2,5 miliardi dell'anno precedente. L'EBITDA rettificato ha mostrato una perdita di 287 milioni di dollari, rispetto a un valore positivo di 134 milioni nel primo trimestre del 2024. Il valore indicativo netto degli asset è diminuito di 336 milioni di dollari, attestandosi a 3,0 miliardi, principalmente a causa delle perdite di 224 milioni nel segmento Investimenti, in particolare nel settore sanitario. Nonostante le difficoltà, IEP ha dichiarato una distribuzione trimestrale di 0,50 dollari per unità depositaria, pagabile il 25 giugno 2025, sebbene rappresenti una riduzione del 50% rispetto alla distribuzione di 1,00 dollari del primo trimestre 2024.
Icahn Enterprises (IEP) reportó pérdidas significativas en el primer trimestre de 2025, con una pérdida neta de 422 millones de dólares (0,79 dólares por unidad), en comparación con una pérdida de 38 millones en el primer trimestre de 2024. Los ingresos de la compañía disminuyeron a 1.9 mil millones de dólares desde 2.5 mil millones año tras año. El EBITDA ajustado mostró una pérdida de 287 millones, frente a un resultado positivo de 134 millones en el primer trimestre de 2024. El valor neto indicativo de los activos disminuyó en 336 millones hasta 3.0 mil millones, principalmente debido a pérdidas de 224 millones en el segmento de Inversiones, especialmente en el sector salud. A pesar de los desafíos, IEP declaró una distribución trimestral de 0.50 dólares por unidad depositaria, pagadera el 25 de junio de 2025, aunque esto representa una reducción del 50% respecto a la distribución de 1.00 dólar en el primer trimestre de 2024.
Icahn Enterprises(IEP)는 2025년 1분기에 큰 손실을 보고했으며, 순손실 4억 2200만 달러(단위당 0.79달러)를 기록해 2024년 1분기 3800만 달러 손실에 비해 악화되었습니다. 회사의 매출은 전년 동기 대비 25억 달러에서 19억 달러로 감소했습니다. 조정 EBITDA는 2024년 1분기 1억 3400만 달러 흑자에서 2억 8700만 달러 적자로 전환되었습니다. 순자산 가치 지표는 3억 3600만 달러 감소해 30억 달러가 되었으며, 이는 주로 투자 부문, 특히 헬스케어 부문에서 발생한 2억 2400만 달러 손실 때문입니다. 어려움에도 불구하고 IEP는 2025년 6월 25일 지급 예정인 단위당 0.50달러 분기 배당금을 선언했으며, 이는 2024년 1분기 1.00달러 배당금의 50% 감소한 수준입니다.
Icahn Enterprises (IEP) a enregistré d'importantes pertes au premier trimestre 2025, avec une perte nette de 422 millions de dollars (0,79 dollar par unité), contre une perte de 38 millions au premier trimestre 2024. Les revenus de la société ont diminué à 1,9 milliard de dollars contre 2,5 milliards un an plus tôt. L'EBITDA ajusté a affiché une perte de 287 millions, contre un bénéfice de 134 millions au premier trimestre 2024. La valeur indicative nette des actifs a diminué de 336 millions pour s'établir à 3,0 milliards, principalement en raison de pertes de 224 millions dans le segment Investissement, notamment dans le secteur de la santé. Malgré ces difficultés, IEP a déclaré une distribution trimestrielle de 0,50 dollar par unité dépositaire, payable le 25 juin 2025, soit une réduction de 50 % par rapport à la distribution de 1,00 dollar du premier trimestre 2024.
Icahn Enterprises (IEP) meldete im ersten Quartal 2025 erhebliche Verluste mit einem Nettoverlust von 422 Millionen US-Dollar (0,79 US-Dollar pro Einheit), verglichen mit einem Verlust von 38 Millionen US-Dollar im ersten Quartal 2024. Die Umsätze des Unternehmens sanken von 2,5 Milliarden auf 1,9 Milliarden US-Dollar im Jahresvergleich. Das bereinigte EBITDA wies einen Verlust von 287 Millionen US-Dollar auf, gegenüber einem positiven Ergebnis von 134 Millionen im ersten Quartal 2024. Der indikative Nettovermögenswert sank um 336 Millionen US-Dollar auf 3,0 Milliarden, hauptsächlich bedingt durch Verluste von 224 Millionen im Investmentsegment, insbesondere im Gesundheitsbereich. Trotz der Herausforderungen erklärte IEP eine vierteljährliche Ausschüttung von 0,50 US-Dollar pro Depositary Unit, zahlbar am 25. Juni 2025, was jedoch eine Reduzierung um 50 % gegenüber der Ausschüttung von 1,00 US-Dollar im ersten Quartal 2024 darstellt.
Positive
  • Maintains quarterly distribution of $0.50 per unit despite losses
  • Strong cash position with $2.18 billion in cash and cash equivalents
  • Diversified business model across multiple sectors
Negative
  • Net loss widened significantly to $422 million from $38 million YoY
  • Revenue declined 24% YoY to $1.9 billion from $2.5 billion
  • Adjusted EBITDA turned negative at -$287 million from positive $134 million YoY
  • Net asset value decreased by $336 million in Q1
  • Quarterly distribution cut by 50% compared to Q1 2024
  • Significant losses of $224 million in Investment segment

Insights

IEP reports devastating Q1 with 11x larger losses, halved distribution, and significant asset value erosion across all key metrics.

Icahn Enterprises' Q1 2025 results reveal severe financial deterioration across all key performance metrics. Net loss ballooned to $422 million from $38 million in Q1 2024—a staggering 1,010% increase. This translates to a loss of $0.79 per unit versus $0.09 last year.

Revenue declined precipitously by 24%, from $2.5 billion to $1.9 billion. Even more alarming is the complete reversal in Adjusted EBITDA, which plummeted from positive $134 million to negative $287 million, signaling fundamental operational challenges throughout the business.

The Investment segment was the primary driver of these disastrous results, posting $224 million in losses concentrated in healthcare investments. Net loss from investment activities more than quadrupled year-over-year from $96 million to $394 million. This poor investment performance directly contributed to the $336 million decrease in indicative net asset value, which has fallen to approximately $3.0 billion.

In a direct blow to unitholders, IEP slashed its quarterly distribution by 50% to $0.50 per unit from $1.00 in the prior year—a clear sign of significant financial distress and cash preservation needs.

The balance sheet shows concerning deterioration with cash and cash equivalents declining by $420 million in just one quarter, while accounts payable increased by $68 million. For a company whose primary business is investments, the magnitude of investment losses represents a fundamental failure in its core operation.

SUNNY ISLES BEACH, Fla., May 7, 2025 /PRNewswire/ -- 

  • Q1 2025 net loss attributable to IEP was $422 million, compared to a loss of $38 million in Q1 2024
  • Q1 2025 Adjusted EBITDA loss attributable to IEP was $287 million, compared to Adjusted EBITDA attributable to IEP of $134 million in Q1 2024
  • Indicative Net Asset Value was approximately $3.0 billion as of March 31, 2025, a decrease of $336 million compared to December 31, 2024
  • IEP declares first quarter distribution of $0.50 per depositary unit 

Financial Summary
(Net loss and Adjusted EBITDA figures in commentary below are attributable to Icahn Enterprises, unless otherwise specified)

For the three months ended March 31, 2025, revenues were $1.9 billion and net loss was $422 million, or $0.79 per depositary unit. For the three months ended March 31, 2024, revenues were $2.5 billion and net loss was $38 million, or a loss of $0.09 per depositary unit. Adjusted EBITDA loss was $287 million for the three months ended March 31, 2025, compared to an Adjusted EBITDA of $134 million for the three months ended March 31, 2024.

As of March 31, 2025, indicative net asset value decreased $336 million compared to December 31, 2024. The decreases was primarily due to losses in the Investment segment of $224 million, driven primarily by losses in the healthcare sector.

On May 5, 2025, the Board of Directors of the general partner of Icahn Enterprises declared a quarterly distribution in the amount of $0.50 per depositary unit, which will be paid on or about June 25, 2025 to depositary unitholders of record at the close of business on May 19, 2025. Depositary unitholders will have until June 12, 2025 to make a timely election to receive either cash or additional depositary units. If a unitholder does not make a timely election, it will automatically be deemed to have elected to receive the distribution in additional depositary units. Depositary unitholders who elect to receive (or who are deemed to have elected to receive) additional depositary units will receive units valued at the volume weighted average trading price of the units during the five consecutive trading days ending June 20, 2025. Icahn Enterprises will make a cash payment in lieu of issuing fractional depositary units to any unitholders electing to receive (or who are deemed to have elected to receive) depositary units.

Icahn Enterprises L.P., a master limited partnership, is a diversified holding company owning subsidiaries currently engaged in the following continuing operating businesses: Investment, Energy, Automotive, Food Packaging, Real Estate, Home Fashion and Pharma.

Caution Concerning Forward-Looking Statements

This release may contain certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, many of which are beyond our ability to control or predict. Forward-looking statements may be identified by words such as "expects," "anticipates," "intends," "plans," "believes," "seeks," "estimates," "will" or words of similar meaning and include, but are not limited to, statements about the expected future business and financial performance of Icahn Enterprises and its subsidiaries. Actual events, results and outcomes may differ materially from our expectations due to a variety of known and unknown risks, uncertainties and other factors, including risks related to economic downturns, substantial competition and rising operating costs; the impacts from the ongoing Russia/Ukraine conflict and conflict in the Middle East, including economic volatility and the impacts of export controls and other economic sanctions; risks related to our investment activities, including the nature of the investments made by the private funds in which we invest, including the impact of the use of leverage through options, short sales, swaps, forwards and other derivative instruments; risk related to our ability to comply with the covenants in our senior notes and the risk of foreclosure on the assets securing our notes; declines in the fair value of our investments, losses in the private funds and loss of key employees; risks related to our ability to continue to conduct our activities in a manner so as to not be deemed an investment company under the Investment Company Act of 1940, as amended, or to be taxed as a corporation; risks related to short sellers and associated litigation and regulatory inquiries; risks relating to our general partner and controlling unitholder; pledges of our units by our controlling unitholder; risks related to our energy business, including the volatility and availability of crude oil, other feed stocks and refined products, declines in global demand for crude oil, refined products and liquid transportation fuels, unfavorable refining margin (crack spread), interrupted access to pipelines, significant fluctuations in nitrogen fertilizer demand in the agricultural industry and seasonality of results; volatile commodity pricing and higher industry utilization and oversupply risks related to potential strategic transactions involving our Energy segment, and the impact of tariffs; risks related to our automotive activities and exposure to adverse conditions in the automotive industry, including as a result of the Chapter 11 filing of our automotive parts subsidiary; risks related to our food packaging activities, including competition from better capitalized competitors, inability of our suppliers to timely deliver raw materials, and the failure to effectively respond to industry changes in casings technology; supply chain issues; inflation, including increased costs of raw materials and shipping; interest rate increases; labor shortages and workforce availability; risks related to our real estate activities, including the extent of any tenant bankruptcies and insolvencies; risks related to our home fashion operations, including changes in the availability and price of raw materials, manufacturing disruptions, and changes in transportation costs and delivery times; political and regulatory uncertainty, including changing economic policy and the imposition of tariffs; and other risks and uncertainties detailed from time to time in our filings with the Securities and Exchange Commission including our Annual Report on Form 10-K and our quarterly reports on Form 10-Q under the caption "Risk Factors". Additionally, there may be other factors not presently known to us or which we currently consider to be immaterial that may cause our actual results to differ materially from the forward-looking statements. Past performance in our Investment segment is not indicative of future performance. We undertake no obligation to publicly update or review any forward-looking information, whether as a result of new information, future developments or otherwise.  

 

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(UNAUDITED) 



Three Months Ended March 31, 


2025


2024


(in millions, except per unit amounts)

Revenues:






Net sales

$

2,002


$

2,253

Other revenues from operations


168



174

Net loss from investment activities


(394)



(96)

Interest and dividend income


83



143

Loss on disposition of assets, net


(3)



(6)

Other income, net


11



2



1,867



2,470

Expenses:






Cost of goods sold


2,016



1,991

Other expenses from operations


151



149

Selling, general and administrative


201



193

Dividend expense


8



20

Impairment


10



Restructuring, net


7



Interest expense


128



136



2,521



2,489

Loss before income tax expense


(654)



(19)

Income tax benefit (expense)


74



(7)

Net loss


(580)



(26)

Less: net (loss) income attributable to non-controlling interests


(158)



12

Net loss attributable to Icahn Enterprises

$

(422)


$

(38)







Net loss attributable to Icahn Enterprises allocated to:






Limited partners

$

(414)


$

(37)

General partner


(8)



(1)


$

(422)


$

(38)







Basic and Diluted income loss per LP unit

$

(0.79)


$

(0.09)

Basic and Diluted weighted average LP units outstanding


523



429

Distributions declared per LP unit

$

0.50


$

1.00

 

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)




March 31, 


December 31, 



2025


2024



(in millions, except unit amounts)

ASSETS







Cash and cash equivalents


$

2,183


$

2,603

Cash held at consolidated affiliated partnerships and restricted cash



2,692



2,636

Investments



2,073



2,310

Due from brokers



1,119



1,624

Accounts receivable, net



503



479

Inventories, net



1,000



897

Property, plant and equipment, net



3,824



3,843

Deferred tax asset



179



160

Derivative assets, net



22



22

Goodwill



288



288

Intangible assets, net



395



409

Assets held for sale



25



25

Other assets



1,178



983

Total Assets


$

15,481


$

16,279

LIABILITIES AND EQUITY







Accounts payable


$

870


$

802

Accrued expenses and other liabilities



1,952



1,547

Deferred tax liabilities



278



331

Derivative liabilities, net



912



756

Securities sold, not yet purchased, at fair value



896



1,373

Due to brokers



37



40

Debt



6,794



6,809

Total liabilities



11,739



11,658















Equity:







Limited partners: Depositary units: 522,736,315 units issued and outstanding at March 31, 2025 and 522,736,315 units issued and outstanding at December 31, 2024



2,563



3,241

General partner



(789)



(775)

Equity attributable to Icahn Enterprises



1,774



2,466

Equity attributable to non-controlling interests



1,968



2,155

Total equity



3,742



4,621

Total Liabilities and Equity


$

15,481


$

16,279

Use of Non-GAAP Financial Measures

The Company uses certain non-GAAP financial measures in evaluating its performance. These include non-GAAP EBITDA and Adjusted EBITDA. EBITDA represents earnings from continuing operations before net interest expense (excluding our Investment segment), income tax (benefit) expense and depreciation and amortization. We define Adjusted EBITDA as EBITDA excluding certain effects of impairment, restructuring costs, transformation costs, certain pension plan expenses, gains/losses on disposition of assets, gains/losses on extinguishment of debt and certain other non-operational charges. We present EBITDA and Adjusted EBITDA on a consolidated basis and on a basis attributable to Icahn Enterprises net of the effects of non-controlling interests. We conduct substantially all of our operations through subsidiaries. The operating results of our subsidiaries may not be sufficient to make distributions to us. In addition, our subsidiaries are not obligated to make funds available to us for payment of our indebtedness, payment of distributions on our depositary units or otherwise, and distributions and intercompany transfers from our subsidiaries to us may be restricted by applicable law or covenants contained in debt agreements and other agreements to which these subsidiaries currently may be subject or into which they may enter into in the future. The terms of any borrowings of our subsidiaries or other entities in which we own equity may restrict dividends, distributions or loans to us. 

We believe that providing EBITDA and Adjusted EBITDA to investors has economic substance as these measures provide important supplemental information of our performance to investors and permits investors and management to evaluate the core operating performance of our business without regard to interest (except with respect to our Investment segment), taxes and depreciation and amortization and certain effects of impairment, restructuring costs, certain pension plan expenses, gains/losses on disposition of assets, gains/losses on extinguishment of debt and certain other non-operational charges. Additionally, we believe this information is frequently used by securities analysts, investors and other interested parties in the evaluation of companies that have issued debt. Management uses, and believes that investors benefit from referring to, these non-GAAP financial measures in assessing our operating results, as well as in planning, forecasting and analyzing future periods. Adjusting earnings for these charges allows investors to evaluate our performance from period to period, as well as our peers, without the effects of certain items that may vary depending on accounting methods and the book value of assets. Additionally, EBITDA and Adjusted EBITDA present meaningful measures of performance exclusive of our capital structure and the method by which assets were acquired and financed. 

EBITDA and Adjusted EBITDA have limitations as analytical tools, and you should not consider them in isolation, or as substitutes for analysis of our results as reported under generally accepted accounting principles in the United States, or U.S. GAAP. For example, EBITDA and Adjusted EBITDA: 

  • do not reflect our cash expenditures, or future requirements for capital expenditures, or contractual commitments; 
  • do not reflect changes in, or cash requirements for, our working capital needs; and 
  • do not reflect the significant interest expense, or the cash requirements necessary to service interest or principal payments on our debt. 

Although depreciation and amortization are non-cash charges, the assets being depreciated or amortized often will have to be replaced in the future, and EBITDA and Adjusted EBITDA do not reflect any cash requirements for such replacements. Other companies in the industries in which we operate may calculate EBITDA and Adjusted EBITDA  differently than we do, limiting their usefulness as comparative measures. In addition, EBITDA and Adjusted EBITDA  do not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations. 

EBITDA and Adjusted EBITDA are not measurements of our financial performance under U.S. GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with U.S. GAAP or as alternatives to cash flow from operating activities as a measure of our liquidity. Given these limitations, we rely primarily on our U.S. GAAP results and use EBITDA and Adjusted EBITDA only as a supplemental measure of our financial performance.  

Use of Indicative Net Asset Value Data

The Company uses indicative net asset value as an additional method for considering the value of the Company's assets, and we believe that this information can be helpful to investors. Please note, however, that the indicative net asset value does not represent the market price at which the depositary units trade. Accordingly, data regarding indicative net asset value is of limited use and should not be considered in isolation.

The Company's depositary units are not redeemable, which means that investors have no right or ability to obtain from the Company the indicative net asset value of units that they own. Units may be bought and sold on The Nasdaq Global Select Market at prevailing market prices. Those prices may be higher or lower than the indicative net asset value of the depositary units as calculated by management. 

See below for more information on how we calculate the Company's indicative net asset value. 






March 31, 


December 31,


2025


2024


(in millions)(unaudited)

Market-valued Subsidiaries and Investments:




   Holding Company interest in Investment Funds(1)

$ 2,479


$ 2,703

   CVR Energy(2)

1,330


1,250

   CVR Partners LP(2)

16


13

Total market-valued subsidiaries and investments

$ 3,825


$ 3,966





Other Subsidiaries:




   Viskase(3)

$ 159


$ 197

   Real Estate Segment(4)

728


743

   WestPoint Home(1)

166


162

   Vivus(1)

215


209





   Automotive Services(5)

521


482

   Automotive Parts(1)

3


9

   Automotive Owned Real Estate Assets(6)

768


768

   Icahn Automotive Group

1,292


1,259





Operating Business Indicative Gross Asset Value

$ 6,385


$ 6,536

   Add: Other Net Assets(7)

(3)


103

Indicative Gross Asset Value

$ 6,382


$ 6,639

   Add: Holding Company cash and cash equivalents(8)

1,318


1,397

   Less: Holding Company debt(8)

(4,699)


(4,699)

Indicative Net Asset Value

$ 3,001


$ 3,337

Indicative net asset value does not purport to reflect a valuation of IEP. The calculated indicative net asset value does not include any value for our Investment Segment other than the fair market value of our investment in the Investment Funds. A valuation is a subjective exercise and indicative net asset value does not necessarily consider all elements or consider in the adequate proportion the elements that could affect the valuation of IEP. Investors may reasonably differ on what such elements are and their impact on IEP. No representation or assurance, express or implied, is made as to the accuracy and correctness of indicative net asset value as of these dates or with respect to any future indicative or prospective results which may vary.  

(1)

Represents GAAP equity attributable to IEP as of each respective date.

(2)

Based on closing share price on each date (or if such date was not a trading day, the immediately preceding trading day) and the number of shares owned by us as of each respective date. 

(3)

Amounts based on market comparables due to lack of material trading volume, valued at 9.0x Adjusted EBITDA for the trailing twelve months ended as of each respective date.  

(4)

For all assets in the Real Estate segment, excluding a debt investment, management performed a valuation with the assistance of third-party consultants to estimate fair-market value, which utilized the results of discounted cashflow and sales comparison methodologies. Different judgments or assumptions would result in different estimates of the value of these holdings. The Real Estate segment's debt investment is fair valued in accordance with GAAP as it has been historically.

(5)

Management performed a valuation on the owned real-estate within the Automotive segment with the assistance of third-party consultants to estimate fair-market value. This analysis utilized property-level market rents, location level profitability, and utilized prevailing cap rates ranging from 7.0% to 9.25%. The valuation assumed that triple net leases are in place for all the locations at rents estimated by management based on market conditions, except for 15 properties management has identified they will exit in the near term, which have been downward adjusted for costs required to reach stabilized rent. There is no assurance we would be able to sell the assets on the timeline or at the prices and lease terms we estimate. Different judgments or assumptions would result in different estimates of the value of these real estate assets. Moreover, although we evaluate and provide our indicative net asset value on a regular basis, the estimated values may fluctuate in the interim, so that any actual transaction could result in a higher or lower valuation. 

(6)

Represents GAAP equity of the Holding Company Segment, excluding cash and cash equivalents, debt and non-cash deferred tax assets or liabilities. As of March 31, 2025 and December 31, 2024, Other Net Assets includes $10 million and $10 million respectively, of Automotive Segment liabilities assumed from the Auto Plus bankruptcy. Furthermore, with respect to March 31, 2025, the distribution payable was adjusted to $75 million, which represents the actual distribution paid subsequent to March 31, 2025.

(7)

Holding Company's balance as of each respective date.

 






Three Months Ended March 31, 


2025


2024





Adjusted EBITDA




Net loss

($580)


($26)

Interest expense, net

94


73

Income tax (benefit) expense

(74)


7

Depreciation and amortization

118


129

EBITDA before non-controlling interests

(442)


183

Impairment

10


-

Restructuring costs

7


-

Loss on disposition of assets, net

2


5

Transformation costs

8


11

Out of period adjustments

-


(2)

Other

4


6

Adjusted EBITDA before non-controlling interests

($411)


$203





Adjusted EBITDA attributable to IEP




Net loss

($422)


($38)

Interest expense, net

83


63

Income tax (benefit) expense

(56)


3

Depreciation and amortization

79


86

EBITDA before non-controlling interests

(316)


114

Impairment

9


-

Restructuring costs

6


-

Loss on disposition of assets, net

2


5

Transformation costs

8


11

Out of period adjustments

-


(2)

Other

4


6

Adjusted EBITDA attributable to IEP

($287)


$134

 

Investor Contact:
Ted Papapostolou, Chief Financial Officer
IR@ielp.com
(800) 255-2737   

 

Cision View original content:https://www.prnewswire.com/news-releases/icahn-enterprises-lp-nasdaq-iep-today-announced-its-first-quarter-2025-financial-results-302448066.html

SOURCE Icahn Enterprises L.P.

FAQ

What was Icahn Enterprises (IEP) earnings per unit in Q1 2025?

IEP reported a loss of $0.79 per depositary unit in Q1 2025, compared to a loss of $0.09 per unit in Q1 2024.

How much is IEP's Q1 2025 dividend distribution?

IEP declared a quarterly distribution of $0.50 per depositary unit, payable on June 25, 2025, which represents a 50% reduction from the $1.00 distribution in Q1 2024.

What caused IEP's losses in Q1 2025?

The losses were primarily driven by the Investment segment, which lost $224 million, particularly in the healthcare sector, contributing to a total net loss of $422 million.

What is IEP's current net asset value as of Q1 2025?

IEP's indicative net asset value was approximately $3.0 billion as of March 31, 2025, representing a decrease of $336 million from December 31, 2024.

How did IEP's revenue change in Q1 2025 compared to Q1 2024?

IEP's revenues decreased to $1.9 billion in Q1 2025 from $2.5 billion in Q1 2024, representing a 24% year-over-year decline.
Icahn Enterprises

NASDAQ:IEP

IEP Rankings

IEP Latest News

IEP Stock Data

4.36B
522.31M
0.08%
87.18%
2.25%
Oil & Gas Refining & Marketing
Motor Vehicle Parts & Accessories
Link
United States
SUNNY ISLES BEACH